TY - JOUR
T1 - Renal Replacement Therapy and Incremental Hemodialysis for Veterans with Advanced Chronic Kidney Disease
AU - Kalantar-Zadeh, Kamyar
AU - Crowley, Susan T.
AU - Beddhu, Srinivasan
AU - Chen, Joline L.T.
AU - Daugirdas, John T.
AU - Goldfarb, David S.
AU - Jin, Anna
AU - Kovesdy, Csaba P.
AU - Leehey, David J.
AU - Moradi, Hamid
AU - Navaneethan, Sankar D.
AU - Norris, Keith C.
AU - Obi, Yoshitsugu
AU - O'Hare, Ann
AU - Shafi, Tariq
AU - Streja, Elani
AU - Unruh, Mark L.
AU - Vachharajani, Tushar J.
AU - Weisbord, Steven
AU - Rhee, Connie M.
N1 - Funding Information:
This work has been supported by the United States Renal Data System Special Study Center grant U01 DK102163. KKZ has been supported by the NIH/NIDDK mid-career award K24-DK091419. KKZ and CPK have been supported by the NIH/NIDDK grant R01-DK096920. CMR has been supported by the NIH/NIDDK early career award K23-DK102903. KCN has been supported by the NIH grants P20-MD000182, UL1TR000124, and P30AG021684. SB has been supported by the NIH grants R01-DK091437 and R21-DK106574. TS has been supported by the R03-DK-104012 and R01-HL-132372. HM and ES are supported by career development awards from the Office of Research and Development of the Department of Veterans Affairs (HM: 1 IK CX 001043-01A2, ES: IK2-CX001266-01). YO has been supported by the Uehara Memorial Foundation Research Fellowship. This study was supported by the grant U01-DK102163 from the National Institute of Health (NIH) to CPK and KKZ, and by resources from the US Department of Veterans Affairs. The data reported here have been supplied by the United States Renal Data System (USRDS). Support for VA/CMS data is provided by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Health Services Research and Development, VA Information Resource Center (Project Numbers SDR 02-237 and 98-004). Opinions expressed in this presentation are those of the authors and do not represent the official opinion of the US Department of Veterans Affairs. We would like to acknowledge Melissa Soohoo, MPH for her contribution in preparing the figures and tables for this manuscript.
Publisher Copyright:
© 2017 Wiley Periodicals, Inc.
PY - 2017/5/1
Y1 - 2017/5/1
N2 - Each year approximately 13,000 Veterans transition to maintenance dialysis, mostly in the traditional form of thrice-weekly hemodialysis from the start. Among >6000 dialysis units nationwide, there are currently approximately 70 Veterans Affairs (VA) dialysis centers. Given this number of VA dialysis centers and their limited capacity, only 10% of all incident dialysis Veterans initiate treatment in a VA center. Evidence suggests that, among Veterans, the receipt of care within the VA system is associated with favorable outcomes, potentially because of the enhanced access to healthcare resources. Data from the United States Renal Data System Special Study Center “Transition-of-Care-in-CKD” suggest that Veterans who receive dialysis in a VA unit exhibit greater survival compared with the non-VA centers. Substantial financial expenditures arise from the high volume of outsourced care and higher dialysis reimbursement paid by the VA than by Medicare to outsourced providers. Given the exceedingly high mortality and abrupt decline in residual kidney function (RKF) in the first dialysis year, it is possible that incremental transition to dialysis through an initial twice-weekly hemodialysis regimen might preserve RKF, prolong vascular access longevity, improve patients’ quality of life, and be a more patient-centered approach, more consistent with “personalized” dialysis. Broad implementation of incremental dialysis might also result in more Veterans receiving care within a VA dialysis unit. Controlled trials are needed to examine the safety and efficacy of incremental hemodialysis in Veterans and other populations; the administrative and health care as well as provider structure within the VA system would facilitate the performance of such trials.
AB - Each year approximately 13,000 Veterans transition to maintenance dialysis, mostly in the traditional form of thrice-weekly hemodialysis from the start. Among >6000 dialysis units nationwide, there are currently approximately 70 Veterans Affairs (VA) dialysis centers. Given this number of VA dialysis centers and their limited capacity, only 10% of all incident dialysis Veterans initiate treatment in a VA center. Evidence suggests that, among Veterans, the receipt of care within the VA system is associated with favorable outcomes, potentially because of the enhanced access to healthcare resources. Data from the United States Renal Data System Special Study Center “Transition-of-Care-in-CKD” suggest that Veterans who receive dialysis in a VA unit exhibit greater survival compared with the non-VA centers. Substantial financial expenditures arise from the high volume of outsourced care and higher dialysis reimbursement paid by the VA than by Medicare to outsourced providers. Given the exceedingly high mortality and abrupt decline in residual kidney function (RKF) in the first dialysis year, it is possible that incremental transition to dialysis through an initial twice-weekly hemodialysis regimen might preserve RKF, prolong vascular access longevity, improve patients’ quality of life, and be a more patient-centered approach, more consistent with “personalized” dialysis. Broad implementation of incremental dialysis might also result in more Veterans receiving care within a VA dialysis unit. Controlled trials are needed to examine the safety and efficacy of incremental hemodialysis in Veterans and other populations; the administrative and health care as well as provider structure within the VA system would facilitate the performance of such trials.
UR - http://www.scopus.com/inward/record.url?scp=85018822046&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85018822046&partnerID=8YFLogxK
U2 - 10.1111/sdi.12601
DO - 10.1111/sdi.12601
M3 - Article
C2 - 28421638
AN - SCOPUS:85018822046
VL - 30
SP - 251
EP - 261
JO - Seminars in Dialysis
JF - Seminars in Dialysis
SN - 0894-0959
IS - 3
ER -